文献速递其他结缔组织病

对未经治疗青少年皮肌炎患者肌肉活检的空间转录组分析揭示:尽管存在疾病相关干扰素驱动特征,仍存在线粒体异常

Spatial transcriptomic analysis of muscle biopsy from patients with treatment-naive juvenile dermatomyositis reveals mitochondrial abnormalities despite disease-related interferon-driven signature.
PubMed 文献 · Ann Rheum Dis · 2025-08-09

本研究对3例未经治疗的青少年皮肌炎(JDM)患者和3例年龄匹配对照的肌肉活检组织进行空间转录组分析,发现JDM肌肉存在干扰素通路激活和线粒体功能障碍,15基因干扰素特征在JDM肌肉和巨噬细胞富集区域显著升高并与临床肌无力相关,而线粒体失调无论干扰素活性或肌力如何均存在,并在19例JDM常规染色和4例JDM的bulk RNAseq数据集中得到验证。

要点

  • JDM肌肉组织较对照显示显著干扰素通路激活和线粒体功能障碍。
  • 15基因干扰素特征在JDM肌肉和巨噬细胞富集区域显著升高,与临床肌无力相关。
  • 线粒体失调表现为呼吸链通路下调,无论干扰素活性或肌力如何均存在。

核心结论

  • 线粒体功能障碍是JDM肌肉的一致病理特征,可能独立于干扰素驱动的炎症。
  • 这些发现提示线粒体靶向治疗在JDM管理中的潜力,并强调需进一步研究探索其治疗价值。

研究设计与样本

  • 研究纳入3例未经治疗的JDM患者和3例年龄匹配对照的肌肉活检,使用Nanostring GeoMx数字空间分析仪进行分析。
  • 根据无免疫细胞的肌纤维、免疫细胞浸润和CD68+巨噬细胞富集选择感兴趣区域,进行差异基因表达、通路分析和通路聚类分析。
  • 关键发现在19例JDM中通过免疫组化和化学染色验证,并在4例JDM的bulk RNAseq数据集中验证。

主要发现

  • JDM肌肉组织较对照显示显著干扰素通路激活和线粒体功能障碍。
  • 15基因干扰素特征在JDM肌肉和巨噬细胞富集区域显著升高,与临床肌无力相关。
  • 线粒体失调表现为呼吸链通路下调,无论干扰素活性或肌力如何均存在。
  • 干扰素驱动特征和线粒体特征在独立的JDM肌肉RNAseq数据集中得到重复;干扰素特征与线粒体失调之间缺乏关联在19例中通过常规染色方法得到验证。
  • 聚类分析显示JDM与对照组织之间以及不同临床表型的JDM患者之间存在不同的转录组谱。

局限性

  • 原文强调需进一步研究探索线粒体靶向治疗的治疗价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to investigate the spatial transcriptomic landscape of muscle tissue from patients with treatment-naive juvenile dermatomyositis (JDM) in comparison to healthy paediatric muscle tissue. METHODS: Muscle biopsies from 3 patients with JDM and 3 age-matched controls were analysed using the Nanostring GeoMx Digital Spatial Profiler. Regions of interest were selected based on muscle fibres without immune cells, immune cell infiltration and CD68+ macrophage enrichment. Differential gene expression, pathway analysis and pathways clustering analysis were conducted. Key findings were validated in 19 cases of JDM using immunohistochemistry and chemical stains, and a bulk RNAseq dataset of 4 cases of JDM. RESULTS: JDM muscle tissues exhibited significant interferon pathway activation and mitochondrial dysfunction compared to controls. A 15-gene interferon signature was significantly elevated in JDM muscle and macrophage-enriched regions, correlating with clinical weakness. In contrast, mitochondrial dysregulation, characterised by downregulated respiratory chain pathways, was present regardless of interferon activity or muscle strength. The interferon-driven and mitochondrial signatures were replicated in an independent RNAseq dataset from JDM muscle; the lack of association between interferon signature and mitochondrial dysregulation was validated in 19 cases by conventional staining methods. Clustering analysis revealed distinct transcriptomic profiles between JDM and control tissues, as well as between patients with JDM with varying clinical phenotypes. CONCLUSIONS: This study highlights mitochondrial dysfunction as a consistent pathological feature in JDM muscle, which may be independent of interferon-driven inflammation. These findings highlight the potential for mitochondrial-targeted therapies in JDM management and emphasise the need for further studies to explore their therapeutic value.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Syntakas AE, Kartawinata M, Evans NML, et al. Spatial transcriptomic analysis of muscle biopsy from patients with treatment-naive juvenile dermatomyositis reveals mitochondrial abnormalities despite disease-related interferon-driven signature. Ann Rheum Dis. 2025. PMID: 40784813. doi:10.1016/j.ard.2025.07.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。